在非ST段升高心肌梗塞患者中,作为预后因素的呈现时的托洛水平
Ranel Loutati1, Nimrod Perel1, Sharon Bruoha2
1Department of Cardiology, Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Clinical cardiology
|October 20, 2023
概括
住院时高灵敏性心脏托罗邦素 (hs-cTn) 水平可以识别高死亡风险的非ST段心肌梗塞 (NSTEMI) 患者. 以hs-cTn水平为指导的早期再注射策略可能会改善结果.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 临床风险分层的临床风险分层
背景情况:
- 对于具有高风险特征的非ST段心肌梗塞 (NSTEMI) 患者,及时输血至关重要.
- 有限的证据表明,在风险分层的NSTEMI患者中使用入院高灵敏心脏托罗素 (hs-cTn) 来加快穿皮冠状动脉干预 (PCI).
研究的目的:
- 调查入院hs-cTn水平与NSTEMI患者全因死亡率之间的关联.
- 评估hs-cTn在风险分层的NSTEMI患者中对潜在的早期干预的有用性.
主要方法:
- 544名入院于三级护理ICCU的NSTEMI患者的回顾性分析 (2019年7月至2022年7月).
- 根据入院hs-cTnI水平,患者被分为四分之一.
- 分析了hs-cTnI四分位数与3年全因死亡率之间的关联.
主要成果:
- 较高的入院hs-cTnI水平与所有原因死亡率的增加有关.
- 在最高的hs-cTnI四分位数中,与最低的四分位数 (7.35%,p=0.03) 相比,死亡率显著更高 (16.2%).
- 在最高四分位数的死亡率调整后的危险比为2.06 (p=0.047).
结论:
- 在NSTEMI患者的高入院hs-cTnI水平表明死亡风险较高.
- 需要进行进一步的前性研究,以评估基于入院热素水平的早期再注射策略对NSTEMI患者死亡率的影响.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
174
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
99
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
99
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
19
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
19
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12


